@@bobw4610 you have to calm down. They are searching for the cure, they can't give it what they have now because they need to study more how it goes and also the FDA have to approve it. Is just matter of time.
From the very first time I started seeing testimonies about you Dr Igho, you gave me full that confidence that I had purchased your medicine, my hiv test would be was negative, now I'm so happy that I could finally have a healthy life thank you so much Dr you really are a Godsent and i appreciate you a lot
From the very first time I started seeing testimonies about you Dr Igho, you gave me full that confidence that I had purchased your medicine, my hiv test would be was negative, now I'm so happy that I could finally have a healthy life thank you so much Dr you really are a Godsent and i appreciate you a lot
From the very first time I started seeing testimonies about you Dr Igho, you gave me full that confidence that I had purchased your medicine, my hiv test would be was negative, now I'm so happy that I could finally have a healthy life thank you so much Dr you really are a Godsent and i appreciate you a lot
as a single mom living with HIV, I would be really glad to take down one load crossing everything to finding the cure. Following this to share also on my channel
DEFINITELY should fast track this if it looks so promising. It will be one of the biggest advancements in history outside of polio vaccines, and antibiotics.
I love that they don't over promise anything and reasonably keep people''s expectations realisitc on the technology and regulations we have in hand. I'm curious what all the platform for other companies to use their technology talk is about. maybe it could help with other conditions and illnesses too.
IN PHILIPPINES AS OF NOW WE FEEL THE EFFECTS OF ARV SHORTAGE PLEASE PAY ATTENTION TO THOSE WHO DON'T HAVE ENOUGH MONEY AND SOME HUBS TRY TO SELL IT FOR 3,000 PESOS PER BOTTLE
Gelmez. Boşuna bekleme. Bunlar fon almak için çabalıyorlar. 1. Aşama çalışmaları bitti ve kimseyi gerçek anlamda tedavi edemediler. Edemezler de. HIV'in kök hücre nakli dışında tedavi edilmesi imkansız.
Type 2 Diabetes can go to remission but it takes a lot of effort to maintain a healthy lifestyle to do that. Syphilis is easily curable with Benzathine Penicillin G. Herpes is incurable but acyclovir will relieve the symptoms. It is not life-shortening, hence, they're prioritizing HIV. And for cancer, similar technologies like CGT in addition to immunotherapy, particularly CAR T cell therapy, and radioligands are numerous. High rates of remission have been observed in those that have failed to be totally removed with surgery.
Exelente discurso no sabemos a dónde ir estamos sin rumbo pero saber q se trabaja día a día en la cura y más q esté bendito hombre Jeff se dedica exclusivamente ala cura del VIH te dan fuerzas para seguir adelante en la vida
Such a shame until now after 2024 we have a company that focus on hiv . Couldn't everyone do it earlier. I hope there is other early companies that we just didn't hear about
@@juanjuan3537 27 de junio de 2023 Addimmune ha completado nuestro ensayo clínico de fase 1 y hemos presentado el informe final a la FDA. Mientras tanto, estamos diseñando el protocolo de ensayo clínico de fase 2 y trabajando para identificar a los fabricantes y los sitios de ensayo. A medida que revisamos los datos de la Fase 1 con posibles colaboradores y socios, la respuesta ha sido constantemente entusiasta con los primeros datos. La interrupción del tratamiento analítico ya ha puesto de relieve una impresionante supresión viral y datos inmunológicos. Esperamos iniciar el ensayo clínico de fase 2 tan pronto como se apruebe el nuevo protocolo. A la espera de la aprobación de la FDA de la Fase 2, la recopilación de datos debe completarse a finales de 2024 o principios de 2025.
@@TuscanWondergracias por tu comentario traía q fuerzas me da para seguir adelante se que muy muy pronto llegará la cura del VIH Dios q así sea echo está
I can’t believe that people like you find a way to point out fingers for no reason when we all should be celebrating. Live your life as you wish but stop judging others. That’s miserable, mean, and unnecessary.
27 de junio de 2023 Addimmune ha completado nuestro ensayo clínico de fase 1 y hemos presentado el informe final a la FDA. Mientras tanto, estamos diseñando el protocolo de ensayo clínico de fase 2 y trabajando para identificar a los fabricantes y los sitios de ensayo. A medida que revisamos los datos de la Fase 1 con posibles colaboradores y socios, la respuesta ha sido constantemente entusiasta con los primeros datos. La interrupción del tratamiento analítico ya ha puesto de relieve una impresionante supresión viral y datos inmunológicos. Esperamos iniciar el ensayo clínico de fase 2 tan pronto como se apruebe el nuevo protocolo. A la espera de la aprobación de la FDA de la Fase 2, la recopilación de datos debe completarse a finales de 2024 o principios de 2025.
Clinical trials take an extensive amount of time because of the safety and efficacy regulations that are in place. All drugs, treatments, and cures must pass rigorous testing to prove that they are not only effective in their purpose but also safe for the public and do not have significant side effects.
One of the primary obstacles in curing HIV lies in the virus's ability to establish latent reservoirs within the body. These reservoirs consist of infected cells that remain dormant and hidden from both the immune system and antiretroviral therapy (ART). Reactivating and eliminating these latent reservoirs has proven challenging, as current treatments primarily target actively replicating virus particles. The persistence of viral latency impedes efforts to completely eradicate the virus from the body. Another challenge is the genetic diversity of HIV. The virus is known for its high genetic variability, resulting in the emergence of various strains and subtypes. The virus mutates rapidly, making it difficult to develop a universal cure. The effectiveness of a single treatment approach may be limited against the diverse array of HIV variants. The genetic diversity of HIV poses a significant hurdle in identifying a cure that can address all strains of the virus. Despite the use of highly effective ART, small amounts of HIV can persist within the body, primarily in reservoirs such as lymphoid tissues. These reservoirs have the potential to reactivate and start producing new virus particles if ART is interrupted or discontinued. Eliminating these reservoirs entirely remains a challenge. The ability of HIV to persist in the body, even with treatment, underscores the difficulty of achieving a definitive cure. Given the formidable challenges in finding a definitive HIV cure, researchers have shifted their focus towards developing a functional cure. A functional cure aims to control the virus without requiring lifelong use of ART. This approach may involve suppressing viral replication to undetectable levels or enabling the immune system to effectively control the virus. A functional cure holds significant promise in enhancing the quality of life for individuals living with HIV. Lifelong ART can be demanding, requiring strict adherence to medication regimens. A functional cure would alleviate the burden of daily medication, reducing treatment-related stress and improving overall well-being. Furthermore, a functional cure that can be achieved within a finite treatment duration would be more cost-effective and accessible, particularly in resource-limited settings where ongoing access to expensive antiretroviral drugs may be challenging. By reducing the dependency on lifelong treatment, a functional cure could enhance the affordability and reach of HIV management strategies. While ART has significantly increased life expectancy and reduced HIV-related complications, it is not without potential side effects and long-term health risks. A functional cure could potentially minimize the risks associated with lifelong treatment, such as drug toxicity and the development of drug resistance. This would contribute to improved long-term health outcomes for individuals living with HIV. Moreover, a functional cure that suppresses viral replication to undetectable levels would greatly reduce the risk of HIV transmission. With the virus being unlikely to be transmitted to sexual partners or through other routes, achieving a functional cure could have a substantial impact on preventing new HIV infections and curbing the epidemic. I haven't yet read the full paper of AGT as to whether theirs is a definitive cure or a functional one but I'm willing to bet they're aiming for a definitive cure.
Maybe all our health problems is from the body needing a answer. Mentally physically could medicine provide us with a answer to a physical and mental question ❤❤❤❤
